414 related articles for article (PubMed ID: 20110413)
41. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
43. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.
Ludwig T; Riethmüller C; Gekle M; Schwerdt G; Oberleithner H
Kidney Int; 2004 Jul; 66(1):196-202. PubMed ID: 15200426
[TBL] [Abstract][Full Text] [Related]
44. New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.
Ciarimboli G; Holle SK; Vollenbröcker B; Hagos Y; Reuter S; Burckhardt G; Bierer S; Herrmann E; Pavenstädt H; Rossi R; Kleta R; Schlatter E
Mol Pharm; 2011 Feb; 8(1):270-9. PubMed ID: 21077648
[TBL] [Abstract][Full Text] [Related]
45. Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity.
Shin KH; Lee KR; Kang MJ; Chae YJ
Chem Biol Interact; 2023 Jul; 379():110504. PubMed ID: 37084994
[TBL] [Abstract][Full Text] [Related]
46. Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity.
Katsuda H; Yamashita M; Katsura H; Yu J; Waki Y; Nagata N; Sai Y; Miyamoto K
Biol Pharm Bull; 2010; 33(11):1867-71. PubMed ID: 21048313
[TBL] [Abstract][Full Text] [Related]
47. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
48. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
[TBL] [Abstract][Full Text] [Related]
49. On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent.
Spreckelmeyer S; Estrada-Ortiz N; Prins GGH; van der Zee M; Gammelgaard B; Stürup S; de Graaf IAM; Groothuis GMM; Casini A
Metallomics; 2017 Dec; 9(12):1786-1795. PubMed ID: 29104982
[TBL] [Abstract][Full Text] [Related]
50. Exacerbation of Cisplatin Cellular Toxicity by Regulation of the Human Organic Cation Transporter 2 through Angiotensin II.
Kantauskaite M; Hucke A; Snieder B; Ciarimboli G
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555515
[TBL] [Abstract][Full Text] [Related]
51. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
[TBL] [Abstract][Full Text] [Related]
52. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
53. Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity.
Yang H; Tang J; Guo D; Zhao Q; Wen J; Zhang Y; Obianom ON; Zhou S; Zhang W; Shu Y
Kidney Int; 2020 Apr; 97(4):765-777. PubMed ID: 32061436
[TBL] [Abstract][Full Text] [Related]
54. Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide.
Miyake T; Mizuno T; Mochizuki T; Kimura M; Matsuki S; Irie S; Ieiri I; Maeda K; Kusuhara H
J Pharm Sci; 2017 Sep; 106(9):2542-2550. PubMed ID: 28479364
[TBL] [Abstract][Full Text] [Related]
55. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
56. Interaction of Cisplatin with the human organic cation transporter 2.
Filipski KK; Loos WJ; Verweij J; Sparreboom A
Clin Cancer Res; 2008 Jun; 14(12):3875-80. PubMed ID: 18559608
[TBL] [Abstract][Full Text] [Related]
57. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
58. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
Ulu R; Dogukan A; Tuzcu M; Gencoglu H; Ulas M; Ilhan N; Muqbil I; Mohammad RM; Kucuk O; Sahin K
Food Chem Toxicol; 2012 May; 50(5):1675-9. PubMed ID: 22414646
[TBL] [Abstract][Full Text] [Related]
59. Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
Kim SJ; Park C; Lee JN; Park R
Toxicol Appl Pharmacol; 2018 Aug; 353():43-54. PubMed ID: 29908243
[TBL] [Abstract][Full Text] [Related]
60. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
Motohashi H; Inui K
AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
